Share

December 2021; 11 (6) Commentary

Strategies to Improve Clinician-Patient Communication Experiences for Patients With Neurologic Conditions

Melissa J. Armstrong, Neal J. Weisbrod, Carma L. Bylund
First published April 14, 2021, DOI: https://doi.org/10.1212/CPJ.0000000000001091
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
37

Share

Article Information

vol. 11 no. 6 e896-e900
DOI: 
https://doi.org/10.1212/CPJ.0000000000001091
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received January 8, 2021
  • Accepted April 7, 2021
  • First Published April 14, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Melissa J. Armstrong, MD, MSc,
    2. Neal J. Weisbrod, MD and
    3. Carma L. Bylund, PhD
  1. Melissa J. Armstrong, MD, MSc,
    2. Scientific Advisory Boards:

    1. (1) Alzheimer's Clinical Trial Consortium/Alzheimer's Therapeutic Research Institute (DSMB) (2) Alzheimer's Disease Cooperative Study (DSMB)

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) American Academy of Neurology, travel to guideline subcommittee meetings (2) Lewy Body Dementia Association, travel to Lewy Body Dementia Association Research Center of Excellence investigator meetings

    Editorial Boards:

    1. (1) Neurology, Level of Evidence Editorial Board, 2012- current

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Parkinson's Disease: Improving Patient Care, Oxford University Press, 2014

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) American Academy of Neurology Evidence-Based Medicine Methodology Consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) ARHQ, K08HS024159, PI, 2015-2020 (2) 1Florida ADRC (AG047266) pilot grant, PI, 2018 (3) Florida Department of Health (20A08), co-PI, 2020-current (4) NIA, P30AG047266, co-I, 2020-current (5) NIA, R01AG068128, PI, 2020-current

    Research Support, Academic Entities:

    1. (1) Mangurian Foundation (University of Florida pilot grant mechanism) (2020)

    Research Support, Foundations and Societies:

    1. (1) Lewy Body Dementia Association Research Center of Excellence

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Neal J. Weisbrod, MD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Florida Department of Health Ed and Ethel Moore Alzheimer Disease Grant, ID 9AZ18, PI, 2 years

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Carma L. Bylund, PhD
    4. Scientific Advisory Boards:

    1. Advisory Board Amgen, Inc.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Hamad Medical Corporation (Doha, Qatar) - Medical Education Workshops. Payment by bank transfer.

    Editorial Boards:

    1. Patient Education & Counseling, Associate Editor, 2020- 2021

    Patents:

    1. NONE

    Publishing Royalties:

    1. Ho E, Bylund C, Van Weert J. (Eds). ICA Encyclopedia of Health Communication. Wiley/Blackwell. (Under contract). Kissane D, Bultz B, Butow P, Bylund CL, Noble S, Wilkinson S. (Eds.) Oxford Textbook of Communication in Oncology and Palliative Care, 2nd Edition. Oxford: Oxford University Press, 2017. Gaff CL, Bylund CL. (Eds). Family Communication About Genetics: Theory and Practice. 2010. New York City: Oxford University Press. Galvin KM, Braithwaite D, Schrodt P, Bylund CL. Family communication: Cohesion and change, 10th edition: Taylor & Francis, 2018. Galvin KM, Braithwaite D, Bylund CL. Family communication: Cohesion and change, 9th edition: Pearson Education, 2015. Previous editions: Galvin KM, Bylund CL, Brommel BJ. Family communication: Cohesion and change, 8th edition: Allyn & Bacon, 2012. Galvin KM, Bylund CL, Brommel BJ. Family communication: Cohesion and change, 7th edition: Allyn & Bacon, 2008; Galvin KM, Bylund CL, Brommel BJ. Family communication: Cohesion and change, 6th edition: Pearson, 2004.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. The Leukemia & Lymphoma Society

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Ed and Ethel Moore Alzheimer's Disease Research Program Communication of dementia diagnoses: Investigating patient, family, & clinician experiences and developing best practices MPIs: Melissa Armstrong and Carma Bylund Direct Costs: $374,660. 05/05/20-4/30/23

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (MJA, NJW), University of Florida College of Medicine, Gainesville; Department of Medicine (NJW), Division of Palliative Care, University of Florida College of Medicine, Gainesville; College of Journalism and Communications (CLB), University of Florida, Gainesville; and Department of Medicine (CLB), University of Florida College of Medicine, Gainesville.
  1. Correspondence
    Dr. Armstrong melissa.armstrong{at}neurology.ufl.edu
View Full Text

Article usage

Article usage: April 2021 to June 2022

AbstractFullPdfSource
Apr 202110301Highwire
May 20214300Highwire
Jun 20214305Highwire
Jul 20216103Highwire
Aug 20215205Highwire
Sep 20214200Highwire
Oct 20215602Highwire
Nov 20214401Highwire
Dec 2021165113Highwire
Jan 202241555Highwire
Feb 202228691Highwire
Mar 20226502Highwire
Apr 20228468Highwire
May 20227560Highwire
Jun 20226111Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me